logo
Plus   Neg
Share
Email

Newell Brands Reiterates FY19 Normalized EPS Outlook, Boosts Sales Forecast

While reporting financial results for the second quarter, consumer goods company Newell Brands (NWL) on Friday reiterated its normalized earnings and core sales guidance for the full-year 2019, while raising net sales outlook. The company also initiated outlook for the third quarter.

For fiscal 2019, the company continues to project normalized earnings in the range of $1.50 to $1.65 per share and core sales to decline in the low-single digit percentage.

Net sales for the full year are now expected between $9.1 billion and $9.3 billion, up from the prior guidance range of $8.2 billion to $8.4 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $1.55 per share on net sales of $8.37 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company projects normalized earnings in a range of $0.55 to $0.60 per share, net sales between $2.42 billion and $2.47 billion and core sales decline of 2 to 4 percent. Analysts expect earnings of $0.54 per share on net sales of $2.23 billion for the quarter.


Further, the company announced its intent to retain the Rubbermaid Commercial Products business, including the related Rubbermaid Outdoor, Closet, Refuse and Garage business lines, which has been classified as held for sale and discontinued operations.

The retention of Rubbermaid Commercial Products will be accretive to operating margins, normalized earnings per share and operating cash flow in 2020 and future years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
RELATED NEWS
Follow RTT